Home Newsfeeds Oppenheimer Downgrades BioCryst Pharmaceuticals to Perform

Oppenheimer Downgrades BioCryst Pharmaceuticals to Perform

Oppenheimer analyst Justin Kim downgrades BioCryst Pharmaceuticals (NASDAQ:BCRX) from Outperform to Perform.

byBenzinga Newsdesk

August 5, 2022

1 minute read

Oppenheimer analyst Justin Kim downgrades BioCryst Pharmaceuticals (NASDAQ:BCRX) from Outperform to Perform.

Abu Dhabi Global Market Picks Rackspace Technology For Cloud Migration

By Anusuya Lahiri

November 17, 12:33 PM

Abu Dhabi Global Market (ADGM), an international financial center in UAE’s capital emirate, collaborated with Rackspace Technology, Inc (NASDAQ:RXT) on…

RXT

Microsoft Expands Game Pass To Newer Geographies To Tap Netflix Kind Of Approach To Gaming On Multi Devices

By Anusuya Lahiri

February 28, 9:34 AM

On February 28, Microsoft Corp (NASDAQ: MSFT) expanded the Game Pass subscription service to dozens of new markets, including in Latin America, the Middle East, and Eastern Europe, almost doubling the number of countries where it's available to 86, Bloomberg

AMZN

DouYu International Hldgs Q4 Sales $243.70M Beat $241.59M Estimate

By Benzinga Newsdesk

March 20, 4:17 AM

DouYu International Hldgs (NASDAQ:DOYU) reported quarterly sales of $243.70 million which beat the analyst consensus estimate of $241.59 million by 0.87 percent. This is a 33.29 percent decrease over sales of $365.30

DOYU